Clinical Trial Update: First Year Growth Response Associated Genetic Markers Validation Phase IV Open-label Study in Growth Hormone Deficient and Turner Syndrome Pre-pubertal Children: the PREDICT Pharmacogenetics Validation Study [Phase 4]

View source ↗

Summary

Phase IV open-label pharmacogenetics study validating genetic markers linked to growth response in pre-pubertal children with growth hormone deficiency and Turn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Growth Hormone Deficiency
• Turner Syndrome

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Idiopathic Growth Hormone Deficiency, Turner Syndrome | Phase 4 | Status: COMPLETED | Results posted: 2014-01-16